AskCPG — Malaysian Clinical Practice Guidelines

Enter values and press Calculate.

Next steps

Recommendations appear after you calculate.

Clinical evidence

Symptom items (nasal congestion, sneezing, rhinorrhea, nasal itching, ocular symptoms) + QoL items (sleep, daily activities, work/school). Each 0–3. Total 0–24.

0–8 mild; 9–16 moderate; 17–24 severe
Intranasal corticosteroids are most effective monotherapy for moderate-to-severe disease
Allergen immunotherapy can modify disease course

Bousquet J et al. J Allergy Clin Immunol 2008 (ARIA)
Brozek JL et al. J Allergy Clin Immunol 2017 (ARIA update)
Seidman MD et al. Otolaryngol Head Neck Surg 2015 (clinical practice guideline)

About the creator

The 5-item symptom severity scale with quality-of-life items follows the ARIA (Allergic Rhinitis and its Impact on Asthma) initiative severity grading framework.

Bousquet J et al. J Allergy Clin Immunol 2008 (ARIA guidelines)